Hunan Heng Chang Pharmaceutical Group Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
1,651
- Latest Deal Type
-
IPO
- (Cancelled)
- Latest Deal Amount
-
$107M
- Investors
-
2
Hunan Heng Chang Pharmaceutical Group General Information
Description
Developer of a B2B e-commerce platform for pharmaceutical sales intended to provide customers with one-stop online drug purchasing services. The company focuses on serving small and medium-sized chain pharmacies, individual pharmacies and primary medical and health institutions, helping its clients to reduce purchasing prices of pharmaceuticals through the B2B model of the Internet platform.
Contact Information
Website
www.hcyy.comCorporate Office
- 1st to 6th Floor, Comprehensive Office Building, Jinpenqiu Resettlement Community
- Qingzhuhu Street, Kaifu District
- Changsha, Hunan
- China
Corporate Office
- 1st to 6th Floor, Comprehensive Office Building, Jinpenqiu Resettlement Community
- Qingzhuhu Street, Kaifu District
- Changsha, Hunan
- China
Hunan Heng Chang Pharmaceutical Group Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. IPO | 02-Jul-2024 | $107M | Cancelled | Profitable | ||
| 1. Later Stage VC | 30-Dec-2020 | Completed | Profitable |
Hunan Heng Chang Pharmaceutical Group Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary |
Hunan Heng Chang Pharmaceutical Group Signals
Hunan Heng Chang Pharmaceutical Group Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ejam Group | Corporation | Minority | ||
| HT-Capital | Growth/Expansion | Minority |
Hunan Heng Chang Pharmaceutical Group Investments (2)
Hunan Heng Chang Pharmaceutical Group’s most recent deal was a Secondary Transaction - Private with King-eagle Med for . The deal was made on 26-Dec-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| King-eagle Med | 26-Dec-2023 | Secondary Transaction - Private | BPO/Outsource Services | ||
| Yineng Pharma | 06-Sep-2023 | Secondary Transaction - Private | Drug Discovery |
Hunan Heng Chang Pharmaceutical Group FAQs
-
When was Hunan Heng Chang Pharmaceutical Group founded?
Hunan Heng Chang Pharmaceutical Group was founded in 2015.
-
Where is Hunan Heng Chang Pharmaceutical Group headquartered?
Hunan Heng Chang Pharmaceutical Group is headquartered in Changsha, China.
-
What is the size of Hunan Heng Chang Pharmaceutical Group?
Hunan Heng Chang Pharmaceutical Group has 1,651 total employees.
-
What industry is Hunan Heng Chang Pharmaceutical Group in?
Hunan Heng Chang Pharmaceutical Group’s primary industry is Business/Productivity Software.
-
Is Hunan Heng Chang Pharmaceutical Group a private or public company?
Hunan Heng Chang Pharmaceutical Group is a Private company.
-
What is Hunan Heng Chang Pharmaceutical Group’s current revenue?
The current revenue for Hunan Heng Chang Pharmaceutical Group is .
-
How much funding has Hunan Heng Chang Pharmaceutical Group raised over time?
Hunan Heng Chang Pharmaceutical Group has raised $22.9M.
-
Who are Hunan Heng Chang Pharmaceutical Group’s investors?
Ejam Group and HT-Capital have invested in Hunan Heng Chang Pharmaceutical Group.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process